EUVIMEDEUVIMED entdecken
Open Access

IL-17A Orchestrates Reactive Oxygen Species/HIF1α–Mediated Metabolic Reprogramming in Psoriasis

Bhavuk Dhamija iD, Soumitra Marathe iD, Vinanti Sawant iD, Moumita Basu iD, Diksha Attrish, Ditipriya Mukherjee iD, Sushant Kumar iD, Medha Gayathri J Pai, Siddhi Wad iD, Abhijeet Sawant, Chitra Nayak iD, Kareenhalli V Venkatesh und 3 weitere

The Journal of Immunology · 2024

DOI: 10.4049/jimmunol.2300319 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Bhavuk Dhamija und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, India. Hauptthemen laut MEDLINE: Interleukin-17, Metabolic Reprogramming, Reactive Oxygen Species, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Department of Science and Technology, Ministry of Science and Technology, India, Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune cell–derived IL-17A is one of the key pathogenic cytokines in psoriasis, an immunometabolic disorder. Although IL-17A is an established regulator of cutaneous immune cell biology, its functional and metabolic effects on nonimmune cells of the skin, particularly keratinocytes, have not been comprehensively explored. Using multiomics profiling and systems biology–based approaches, we systematically uncover significant roles for IL-17A in the metabolic reprogramming of human primary keratinocytes (HPKs). High-throughput liquid chromatography–tandem mass spectrometry and nuclear magnetic resonance spectroscopy revealed IL-17A–dependent regulation of multiple HPK proteins and metabolites of carbohydrate and lipid metabolism. Systems-level MitoCore modeling using flux-balance analysis identified IL-17A–mediated increases in HPK glycolysis, glutaminolysis, and lipid uptake, which were validated using biochemical cell-based assays and stable isotope-resolved metabolomics. IL-17A treatment triggered downstream mitochondrial reactive oxygen species and HIF1α expression and resultant HPK proliferation, consistent with the observed elevation of these downstream effectors in the epidermis of patients with psoriasis. Pharmacological inhibition of HIF1α or reactive oxygen species reversed IL-17A–mediated glycolysis, glutaminolysis, lipid uptake, and HPK hyperproliferation. These results identify keratinocytes as important target cells of IL-17A and reveal its involvement in multiple downstream metabolic reprogramming pathways in human skin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-17Metabolic ReprogrammingReactive Oxygen SpeciesHypoxia-Inducible Factor 1, alpha SubunitPsoriasisCells, CulturedHumansKeratinocytesCell ProliferationMaleFemaleAdolescentYoung AdultAdultMiddle AgedUp-RegulationLipid Metabolism

Substanzen

Interleukin-17Reactive Oxygen SpeciesHIF1A protein, humanHypoxia-Inducible Factor 1, alpha Subunit

Autor:innen und Institutionen

  • Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, India.
  • Plastic Surgery Department, Topiwala National Medical College and B.Y.L. Nair Charitable Hospital, Mumbai, India.
  • Skin and Venereal Diseases Department, Topiwala National Medical College and B.Y.L. Nair Charitable Hospital, Mumbai, India.
  • Department of Chemical Engineering, Indian Institute of Technology Bombay, Mumbai, India.
  • Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

ORCID-Profile: Bhavuk Dhamija, Soumitra Marathe, Vinanti Sawant, Moumita Basu, Ditipriya Mukherjee, Sushant Kumar, Siddhi Wad, Chitra Nayak, Steven R Barthel, Rahul Purwar

Förderung

  • NCI NIH HHS
  • Department of Science and Technology, Ministry of Science and Technology, India
  • Indian Council of Medical Research

Zitieren

APA

Dhamija, B., Marathe, S., Sawant, V., Basu, M., Attrish, D., Mukherjee, D., Kumar, S., Pai, M. G. J., Wad, S., Sawant, A., Nayak, C., Venkatesh, K. V., Srivastava, S., Barthel, S. R., & Purwar, R. (2024). IL-17A Orchestrates Reactive Oxygen Species/HIF1α–Mediated Metabolic Reprogramming in Psoriasis. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300319

Vancouver

Dhamija B, Marathe S, Sawant V, Basu M, Attrish D, Mukherjee D, et al. IL-17A Orchestrates Reactive Oxygen Species/HIF1α–Mediated Metabolic Reprogramming in Psoriasis. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2300319

BibTeX
@article{Dhamija2024,
  author = {Dhamija, Bhavuk and Marathe, Soumitra and Sawant, Vinanti and Basu, Moumita and Attrish, Diksha and Mukherjee, Ditipriya and Kumar, Sushant and Pai, Medha Gayathri J and Wad, Siddhi and Sawant, Abhijeet and Nayak, Chitra and Venkatesh, Kareenhalli V and Srivastava, Sanjeeva and Barthel, Steven R and Purwar, Rahul},
  title = {IL-17A Orchestrates Reactive Oxygen Species/HIF1α–Mediated Metabolic Reprogramming in Psoriasis},
  journal = {The Journal of Immunology},
  year = {2024},
  doi = {10.4049/jimmunol.2300319}
}
Kostenlos starten →